CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Zentiva against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJun 25, 2025
Novel Pharmaceutical CompositionNOVARTISJan 10, 2025
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 14, 2024
Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv InfectionVIIV HEALTHCARESep 13, 2024
Combination Therapy For The Treatment Of Ovarian CancerFHOFFMANN LA ROCHEAug 28, 2024
New UseNOVARTISJul 11, 2024
Pharmaceutical FormulationsGILEAD SCIENCESDec 11, 2023
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 8, 2023
Pharmaceutical FormulationsGILEAD SCIENCESNov 29, 2023
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023

Explore Zentiva's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 28, 2018Stable Ivabradine Formulations1

Top competitors of Zentiva

List of top competitors of Zentiva based on patent oppositions.